3.36
Icad Inc stock is traded at $3.36, with a volume of 222.39K.
It is down -3.17% in the last 24 hours and up +63.11% over the past month.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
See More
Previous Close:
$3.47
Open:
$3.47
24h Volume:
222.39K
Relative Volume:
0.52
Market Cap:
$91.45M
Revenue:
$18.94M
Net Income/Loss:
$-2.71M
P/E Ratio:
-24.00
EPS:
-0.14
Net Cash Flow:
$-4.92M
1W Performance:
+5.00%
1M Performance:
+63.11%
6M Performance:
+180.00%
1Y Performance:
+140.00%
Icad Inc Stock (ICAD) Company Profile
Name
Icad Inc
Sector
Industry
Phone
603-882-5200
Address
98 SPIT BROOK ROAD, SUITE 100, NASHUA, NH
Compare ICAD with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ICAD
Icad Inc
|
3.36 | 91.45M | 18.94M | -2.71M | -4.92M | -0.14 |
![]()
ABT
Abbott Laboratories
|
128.72 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
105.49 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
![]()
SYK
Stryker Corp
|
391.91 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
89.89 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
![]()
EW
Edwards Lifesciences Corp
|
70.94 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Icad Inc Stock (ICAD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-18-22 | Downgrade | Guggenheim | Buy → Neutral |
Apr-22-21 | Initiated | Guggenheim | Buy |
Mar-23-21 | Initiated | BTIG Research | Buy |
Feb-26-21 | Initiated | Oppenheimer | Outperform |
Jan-29-21 | Initiated | Cantor Fitzgerald | Overweight |
Dec-03-20 | Initiated | B. Riley Securities | Buy |
Feb-05-20 | Initiated | JMP Securities | Mkt Outperform |
Jan-09-20 | Initiated | Lake Street | Buy |
Dec-09-08 | Reiterated | Canaccord Adams | Buy |
Aug-01-08 | Reiterated | MDB Capital Group | Buy |
May-14-08 | Reiterated | Canaccord Adams | Buy |
Feb-14-08 | Initiated | Sun Trust Rbsn Humphrey | Buy |
Jan-24-07 | Reiterated | Dawson James | Speculative Buy |
View All
Icad Inc Stock (ICAD) Latest News
Icad Inc (ICAD) deserves closer scrutiny - US Post News
The Psychology of Icad Inc Inc. (ICAD) Price Performance: Understanding Market Sentiment - The InvestChronicle
Why iCAD Inc (ICAD) Is Skyrocketing So Far In 2025 - Yahoo Finance
Short Interest in iCAD, Inc. (NASDAQ:ICAD) Decreases By 14.5% - MarketBeat
iCAD (NASDAQ:ICAD) Downgraded to Sell Rating by StockNews.com - MarketBeat
Earnings call transcript: iCAD Q3 2024 sees revenue rise, SaaS shift - MSN
iCAD (NASDAQ:ICAD) Rating Lowered to “Sell” at StockNews.com - Defense World
Why ICAD Stock Is Climbing Today - MSN
iCAD, Inc. Pre-Announces Estimated Q4 2024 Revenue - Defense World
iCAD stock soars to 52-week high, reaching $2.67 amid robust gains - MSN
After Leaping 46% iCAD, Inc. (NASDAQ:ICAD) Shares Are Not Flying Under The Radar - Simply Wall St
iCAD stock soars to 52-week high, reaching $2.67 amid robust gains By Investing.com - Investing.com South Africa
iCAD Shares Climb After 4Q Sales Guidance Beats Expectations - MarketWatch
ICAD, Inc. Provides Earnings Guidance for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
iCAD Pre-Announces Estimated Q4 2024 Revenue - GlobeNewswire
iCAD Reports Strong Q4: 106 Deals Closed, T-ARR Grows 11% to $9.8M - StockTitan
Zacks Market Edge Highlights: FiscalNote, and iCAD - Yahoo Finance
iCAD, Inc. (NASDAQ:ICAD) Sees Significant Decline in Short Interest - MarketBeat
Discover the AI Stocks Under $5 That Investors Are Talking About - Kuhinje EWE Daily
2 AI Stocks Under $5 - Yahoo Finance
Strategic Acquisitions by Hologic and iCAD Shape Future of CAD Market - openPR
iCAD (NASDAQ:ICAD) Shares Pass Above 200-Day Moving AverageShould You Sell? - MarketBeat
FDA Clears iCAD’s ProFound Detection Version 4.0 - MPO-mag
iCAD (NASDAQ:ICAD) Shares Pass Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Head-To-Head Comparison: iCAD (NASDAQ:ICAD) & Todos Medical (OTCMKTS:TOMDF) - Defense World
iCAD (NASDAQ:ICAD) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
New Research Addresses Image Based AI-Risk, Detection and Breast Arterial Calcifications Assessment - Imaging Technology News
iCAD (NASDAQ:ICAD) Stock Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
SABCS 2024: New Research Assesses iCAD’s Image Based - GlobeNewswire
iCAD's AI Breast Cancer Detection Breakthrough: New Research Shows Superior Risk Assessment Performance - StockTitan
CORRECTION – iCAD Advances Fight Against Breast Cancer with - GlobeNewswire
iCAD's New AI Breakthrough Boosts Breast Cancer Detection by 23%, Partners with Cascaid Health - StockTitan
US Penny Stocks To Watch In December 2024 - Simply Wall St
Breast Cancer Brachytherapy Market Growth in Future Scope - openPR
Global Computer-Aided Detection (CAD) Software Market Size, - openPR
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024 - The Manila Times
iCAD Advances Fight Against Breast Cancer with FDA-cleared, - GlobeNewswire
iCAD's New AI Cancer Detection System Boosts Accuracy by 22%, Partners with Cascaid Health | ICAD Stock News - StockTitan
U.S. Computer-Aided Detection (CAD) Market Future Business - openPR
Computer Aided Detection (CAD) Market: Expected Positive - openPR
Need To Know: Analysts Just Made A Substantial Cut To Their iCAD, Inc. (NASDAQ:ICAD) Estimates - Yahoo Finance
iCAD Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
iCAD, Inc. (NASDAQ:ICAD) Q3 2024 Earnings Call Transcript - Insider Monkey
ICAD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Earnings call: iCAD reports steady growth with SaaS transition By Investing.com - Investing.com Canada
Q3 2024 ICAD Inc Earnings Call - Cbainfo
Icad Inc Stock (ICAD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):